UOC
CMD

UBS O'Connor’s Cantel Medical Corporation CMD Stock Holding History

UBS O'Connor’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-700,000
Closed -$55.9M – 1141
2021
Q1 		$55.9M Buy
+700,000
New +$54.7M 0.81% 18

UBS O'Connor's CMD Position: Q2 2021 in Review

UBS O'Connor sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 700,000 shares — an estimated $55.9M sold.

UBS O'Connor first reported a position in CMD in Q1 2021 and held it in 1 quarter. The position peaked at $55.9M in Q1 2021. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

  • UBS O'Connor reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
  • UBS O'Connor sold 700,000 Cantel Medical Corporation shares in Q2 2021, an estimated $55.9M.
  • UBS O'Connor first reported a position in Cantel Medical Corporation in Q1 2021 and held it in 1 quarter.
  • UBS O'Connor's Cantel Medical Corporation position peaked at $55.9M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on UBS O'Connor's 13F filing for Q2 2021, filed 13 Aug 2021.